GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will have access to real-time, step-by-step guidance to capture diagnostic-quality images and automated ejection fraction estimation to help inform clinical decisions across cardiac settings. Vscan Air SL with Caption AI will debut at the 2024 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place April 6 ?

8, 2024 in Atlanta. Cardiovascular disease (CVD) is the leading cause of death globally, and the prevalence is expected to continue rising as people live longer and the population increases.1 Early detection of heart disease is critical to improving patient outcomes, but providing rapid echocardiographic assessments at the point of care can be difficult in resource-constrained facilities and practices. Vscan Air SL with Caption AI is designed to lower the threshold for healthcare professionals to be able to capture cardiac images so that even non-expert ultrasound users can take a quick look at patients?

hearts. Caption AI provides real-time visual guidance to prompt users on probe movements and includes a quality meter to ensure the user obtains the best possible images. Once an image is captured, the AutoEF feature automatically calculates a left ventricular ejection fraction (LVEF).

In addition, users can efficiently scan with AutoCapture and Save Best Clip features to capture the best quality image from each view. The ultraportable Vscan Air SL provides high levels of depth, resolution and sensitivity in imaging performance with single crystal transducer technology. The latest integration of Caption AI builds on GE HealthCare?s history and innovation in handheld ultrasound?having introduced the pioneering Vscan in 2010 as the first color, pocket-sized ultrasound device?and is helping to make next-generation ultrasound care accessible to even more patients.

The launch of Vscan Air SL with Caption AI advances GE HealthCare?s vision and efforts to strengthen precision care, joining the approximately 60 AI-enabled medical device authorizations from GE HealthCare in the United States ? more than any other medical device company. Of these, approximately 30 are AI-enabled ultrasound innovations.

In addition to Vscan Air SL, GE HealthCare will also showcase its suite of innovative products and solutions across the cardiology care pathway at ACC 2024, including CardioVisio for Atrial Fibrillation, a digital, patient-centric clinical decision support tool, which includes the most recent ACC guidelines. Telling the story of the heart with integrated cardiology technology, the comprehensive portfolio of cardiovascular solutions delivers across the full continuum of patient care from diagnosis and treatment all the way through post-treatment monitoring.